Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Pain, Postoperative 17Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Inflammation 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

Temozolomide 2Sodium Chloride 2Dexmedetomidine 2tucatinib 1tipifarnib 1sagopilone 1pembrolizumab 1Trastuzumab 1Tissue Banks 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1Dasatinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Central Nervous System Diseases × Dexmedetomidine × Clear all
NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown
700 enrolled
CNS

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡